Genomics and pharmacogenomics in anticancer drug development and clinical response /

Bibliographic Details
Other Authors: Innocenti, Federico
Format: Book
Language:English
Published: Totowa, N.J. : Humana Press, [2008]
Series:Cancer drug discovery and development.
Subjects:
Table of Contents:
  • Toward the realization of the promise of microarrays in oncology
  • Cell-based models to identify genetic variants contributing to anticancer drug response
  • Proteomic analysis in cancer patients
  • MicroRNAs and discovery of new targets
  • Pharmacogenomics of the National Cancer Institute's 60-tumor cell panel
  • Use of single-nucleotide polymorphism array for tumor aberrations in gene copy numbers
  • Concordance between tumor and germline DNA
  • Epidermal growth factor receptor mutations and sensitivity to selective kinase inhibitors in human lung cancer
  • BCR-ABL mutations and imatinib resistance in chronic myeloid leukemia patients
  • Role of thymidylate synthase gene variations in colorectal cancer patients
  • Thiopurines in the treatment of childhood acute lymphoblastic leukemia and genetic variants of the thiopurine S-Methyltransferase gene
  • Impact of polymorphisms on the clinical outcomes of monoclonal antibody therapy against hematologic malignancies
  • DNA repair and mitotic checkpoint genes as potential predictors of chemotherapy response in non-small-cell lung cancer
  • Dihydropyrimidine dehydrogenase (Dpyd) gene polymorphism : portrait of a serial killer
  • Impact of UDP- glucuronosyltransferase 1A haplotypes on irinotecan treatment
  • Microarray profiling in breast cancer patients
  • Role of the folate-pathway and the thymidylate synthase genes in pediatric acute lymphoblastic leukemia treatment response
  • Pharmacogenomics in drug development : a pharmaceutical industry perspective
  • Identification of pharmacogenomic biomarker classifiers in cancer drug development
  • Toxicogenomics application to oncology drug development
  • Strategies to identify pharmacogenomic biomarkers : candidate gene, pathway-based, and genome-wide approaches